Barker, Peter E.

Email: peter.barker@nist.gov
Fax: (301) 975-8505
DMCC Person ID: 996
EDRN Title: EDRN Associate Member
Specialty: None given

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
Establishment of a serum standard for use in high-throughput proteomic 0 0
Validation of the Mutagen Sensitivity and Chromosomal Hotspot Assays 0 1

Closed Protocols

Protocol Name Biomarkers Datasets
Mitochondrial genome deletion aids in the identification of false- and true-negative prostate needle core biopsy specimens 0 0

Publications

Publication Name PubMed ID Journal
Cancer biomarker validation: standards and process: roles for the National Institute of Standards and Technology (NIST). 12724219 Ann. N. Y. Acad. Sci.
Considerations on development, validation, application, and quality control of immuno(metric) biomarker assays in clinical cancer research: an EORTC-NCI working group report. 14612946 Int. J. Oncol.
Evaluation of two mitochondrial DNA biomarkers for prostate cancer detection. 26406418 Cancer Biomark
High-throughput analysis of telomerase by capillary electrophoresis. 12652580 Electrophoresis
Mitochondrial genome deletion aids in the identification of false- and true-negative prostate needle core biopsy specimens. 18089489 Am J Clin Pathol
Nanotechnology in early detection of cancer. 12004006 Lab. Invest.
Nanotechnology: Emerging Developments and Early Detection of Cancer. A two-day workshop sponsored by the National Cancer Institute and the National Institute of Standards and Technology, August 30-31 2001, on the National Institute of Standards and Technology Campus, Gaithersburg, MD, USA. 12590168 Dis. Markers
NIST physical standards for DNA-based medical testing. 11835524 J. Clin. Lab. Anal.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Version 5.1.0